In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
Background: The emergence of Coronavirus disease (COVID-19) has been declared a pandemic and made a medical emergency worldwide. Various attempts have been made, including optimizing effective treatments against the disease or developing a vaccine. Since the SARS-CoV-2 protease crystal structure has...
Saved in:
Main Authors: | Saipul Maulana (Author), Tutik S. Wahyuni (Author), Prihartini Widiyanti (Author), Muhammad S. Zubair (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of SARS-CoV 3CL protease by flavonoids
by: Seri Jo, et al.
Published: (2020) -
Plant Products as Inhibitors of Coronavirus 3CL Protease
by: Anirban Mandal, et al.
Published: (2021) -
Hybrid Approach to Identifying Druglikeness Leading Compounds against COVID-19 3CL Protease
by: Imra Aqeel, et al.
Published: (2022) -
Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022) -
SmCL3, a gastrodermal cysteine protease of the human blood fluke Schistosoma mansoni.
by: Jan Dvorák, et al.
Published: (2009)